Literature DB >> 32118264

Modeling chemical effects on breast cancer: the importance of the microenvironment in vitro.

Molly M Morgan1, Linda A Schuler2,3, Jordan C Ciciliano1, Brian P Johnson4, Elaine T Alarid3,5, David J Beebe1,4,3.   

Abstract

Accumulating evidence suggests that our ability to predict chemical effects on breast cancer is limited by a lack of physiologically relevant in vitro models; the typical in vitro breast cancer model consists of the cancer cell and excludes the mammary microenvironment. As the effects of the microenvironment on cancer cell behavior becomes more understood, researchers have called for the integration of the microenvironment into in vitro chemical testing systems. However, given the complexity of the microenvironment and the variety of platforms to choose from, identifying the essential parameters to include in a chemical testing platform is challenging. This review discusses the need for more complex in vitro breast cancer models and outlines different approaches used to model breast cancer in vitro. We provide examples of the microenvironment modulating breast cancer cell responses to chemicals and discuss strategies to help pinpoint what components should be included in a model.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  3D; breast cancer; drugs; environmental chemicals; microenvironment

Mesh:

Substances:

Year:  2020        PMID: 32118264      PMCID: PMC7060306          DOI: 10.1093/intbio/zyaa002

Source DB:  PubMed          Journal:  Integr Biol (Camb)        ISSN: 1757-9694            Impact factor:   2.192


  139 in total

1.  Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells.

Authors:  Daniela Loessner; Kathryn S Stok; Matthias P Lutolf; Dietmar W Hutmacher; Judith A Clements; Simone C Rizzi
Journal:  Biomaterials       Date:  2010-08-14       Impact factor: 12.479

Review 2.  Crosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironment.

Authors:  Esak Lee; Niranjan B Pandey; Aleksander S Popel
Journal:  Expert Rev Mol Med       Date:  2015-01-30       Impact factor: 5.600

3.  Transition to invasion in breast cancer: a microfluidic in vitro model enables examination of spatial and temporal effects.

Authors:  Kyung Eun Sung; Ning Yang; Carolyn Pehlke; Patricia J Keely; Kevin W Eliceiri; Andreas Friedl; David J Beebe
Journal:  Integr Biol (Camb)       Date:  2010-12-07       Impact factor: 2.192

4.  Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2+ Breast Cancer.

Authors:  Ariella B Hanker; Mónica Valeria Estrada; Giampaolo Bianchini; Preston D Moore; Junfei Zhao; Feixiong Cheng; James P Koch; Luca Gianni; Darren R Tyson; Violeta Sánchez; Brent N Rexer; Melinda E Sanders; Zhongming Zhao; Thomas P Stricker; Carlos L Arteaga
Journal:  Cancer Res       Date:  2017-04-10       Impact factor: 12.701

Review 5.  The Extracellular Matrix Modulates the Metastatic Journey.

Authors:  FuiBoon Kai; Allison P Drain; Valerie M Weaver
Journal:  Dev Cell       Date:  2019-05-06       Impact factor: 12.270

6.  Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition.

Authors:  Thorarinn Gudjonsson; Lone Rønnov-Jessen; René Villadsen; Fritz Rank; Mina J Bissell; Ole William Petersen
Journal:  J Cell Sci       Date:  2002-01-01       Impact factor: 5.285

Review 7.  An overview of mammographic density and its association with breast cancer.

Authors:  Shayan Shaghayeq Nazari; Pinku Mukherjee
Journal:  Breast Cancer       Date:  2018-04-12       Impact factor: 4.239

8.  Stromal Infiltration of Tumor-Associated Macrophages Conferring Poor Prognosis of Patients with Basal-Like Breast Carcinoma.

Authors:  Mu Yang; Zhenhua Li; Meijing Ren; Shuai Li; Lanjing Zhang; Xinmin Zhang; Fangfang Liu
Journal:  J Cancer       Date:  2018-06-06       Impact factor: 4.207

Review 9.  Targeted therapies in breast cancer: New challenges to fight against resistance.

Authors:  Viviana Masoud; Gilles Pagès
Journal:  World J Clin Oncol       Date:  2017-04-10

10.  Contribution of three-dimensional architecture and tumor-associated fibroblasts to hepcidin regulation in breast cancer.

Authors:  Nicole Blanchette-Farra; Daniel Kita; Anna Konstorum; Lia Tesfay; David Lemler; Poornima Hegde; Kevin P Claffey; Frank M Torti; Suzy V Torti
Journal:  Oncogene       Date:  2018-04-26       Impact factor: 9.867

View more
  5 in total

Review 1.  Studying Adipose Tissue in the Breast Tumor Microenvironment In Vitro: Progress and Opportunities.

Authors:  David Mertz; Jason Sentosa; Gary Luker; Shuichi Takayama
Journal:  Tissue Eng Regen Med       Date:  2020-09-16       Impact factor: 4.169

2.  A bioengineered lymphatic vessel model for studying lymphatic endothelial cell-cell junction and barrier function.

Authors:  Aria R Henderson; Isabelle S Ilan; Esak Lee
Journal:  Microcirculation       Date:  2021-10-04       Impact factor: 2.679

3.  A bioengineered organotypic prostate model for the study of tumor microenvironment-induced immune cell activation.

Authors:  Sheena C Kerr; Molly M Morgan; Amani A Gillette; Megan K Livingston; Karina M Lugo-Cintron; Peter F Favreau; Logan Florek; Brian P Johnson; Joshua M Lang; Melissa C Skala; David J Beebe
Journal:  Integr Biol (Camb)       Date:  2020-10-16       Impact factor: 3.177

Review 4.  Engineering complexity in human tissue models of cancer.

Authors:  Kacey Ronaldson-Bouchard; Ilaria Baldassarri; Daniel Naveed Tavakol; Pamela L Graney; Maria Samaritano; Elisa Cimetta; Gordana Vunjak-Novakovic
Journal:  Adv Drug Deliv Rev       Date:  2022-03-09       Impact factor: 17.873

Review 5.  Adverse outcome pathways for ionizing radiation and breast cancer involve direct and indirect DNA damage, oxidative stress, inflammation, genomic instability, and interaction with hormonal regulation of the breast.

Authors:  Jessica S Helm; Ruthann A Rudel
Journal:  Arch Toxicol       Date:  2020-05-13       Impact factor: 5.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.